High materiality8/10
Immuneering initiated with an Overweight at Cantor Fitzgerald
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald initiated IMRX with an Overweight rating; target $17; current price $5.10.
- Cantor Fitzgerald initiated Overweight on IMRX; target $17; price $5.10.
Key facts
- 01
Target: $17
- 02
Posted price: $5.1
- 03
Analyst firm: Cantor Fitzgerald
- 04
Analyst: Li Watsek
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.